Log in Book a Demo

US Pharma & Biotech Infectious Diseases - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Infectious Diseases category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
uqora.com 17.32
prevnar20.com 13.04
treatmyuti.com 9.2
hellowisp.com 6.65
paxlovid.com 6.18
talk-prep.com 4.58
abrysvo.com 3.9
solvwellness.com 3.75
viivhealthcare.com 2.5
comirnaty.com 2.23
others 30.65

Copyright © Adthena. All rights reserved.

In the PPC landscape, ‘uqora.com’ leads with 17.32% click share, followed by ‘prevnar20.com’ at 13.04%. ‘Others’ collectively hold a significant 30.65%, highlighting diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date treatmyuti.com prevnar20.com talk-prep.com uqora.com viivhealthcare.com sunlencahcp.com abrysvo.com paxlovid.com cabenuva.com dovato.com
2025/03/01 9.46% 4.36% 4.25% 5.01% 0.51% 2.58% 3.67% 6.17% 14.33% 2.43%
2025/03/02 2.35% 3.56% 6.35% 9.45% 0.61% 2.64% 0.8% 7.61% 8.07% 14.33%
2025/03/03 1.02% 3.46% 5.99% 0.3% 0.79% 2.71% 0.62% 13.62% 7.74% 21.76%
2025/03/04 0.39% 6.57% 4.69% 5.9% 1.13% 2.34% 1.4% 8.12% 9.32% 13.08%
2025/03/05 0% 16.79% 2.66% 17.54% 2.88% 5.01% 2% 1.19% 1.73% 0.33%
2025/03/06 0% 25.73% 4.62% 2.78% 6.32% 6.99% 5.41% 0.98% 1.32% 0.24%
2025/03/07 6.69% 10.59% 2.53% 12.65% 4.59% 3.54% 1.33% 4.9% 2.67% 4.66%
2025/03/08 2.51% 16.02% 5.76% 5.1% 6.11% 7.15% 3.93% 2.44% 1.65% 3.47%
2025/03/09 0.11% 18.83% 6.58% 8.34% 3.94% 7.51% 3.95% 0.73% 0.89% 0.15%
2025/03/10 8.92% 24.06% 8.53% 8.2% 3.56% 8.76% 1.57% 0.4% 0.44% 0.07%
2025/03/11 10.36% 23.81% 5.19% 20.01% 3.74% 6.82% 3.11% 0.27% 0.17% 0.05%
2025/03/12 1.29% 27.73% 9.57% 0.79% 7.47% 3.51% 4.31% 0.1% 0.16% 0.04%
2025/03/13 2.02% 33.37% 9.31% 0.03% 6.95% 5.78% 7.15% 0.1% 0.15% 0.04%
2025/03/14 0.45% 28.91% 10.47% 0% 4% 4.49% 4.45% 0.09% 0.13% 0.04%
2025/03/15 0.81% 32.76% 12.4% 0% 3.39% 8.66% 4.49% 0.06% 0.07% 0.03%
2025/03/16 0.91% 27.8% 13.43% 0% 7.03% 6.47% 4.89% 0% 0% 0%
2025/03/17 1.05% 28.74% 6.35% 4.84% 1.67% 5.33% 8.15% 0% 0% 0%
2025/03/18 0% 34.64% 8.83% 11.47% 1.64% 7% 4.7% 0% 0% 0%
2025/03/19 9.03% 22.28% 8.36% 10.17% 1.56% 2.93% 1.55% 0% 0% 0%
2025/03/20 4.51% 24.68% 10.01% 18.35% 1.28% 5.63% 5.88% 0% 0% 0%
2025/03/21 0.45% 32.24% 10.02% 6.26% 3.75% 3.79% 8.64% 0% 0% 0%
2025/03/22 1.26% 24.38% 13.95% 3.73% 3.81% 7.1% 5.18% 0% 0% 0%
2025/03/23 12.08% 21.99% 5.83% 3.85% 3.05% 6.88% 2.97% 0% 0% 0%
2025/03/24 0.4% 15.92% 15.46% 0% 3.28% 9.19% 7.17% 0% 0% 0%
2025/03/25 11.49% 28.6% 10.78% 7.61% 1.83% 4.56% 4.42% 0% 0% 0%
2025/03/26 3.09% 22.51% 18.55% 2.8% 3.56% 4.22% 5.33% 0% 0.19% 0.16%
2025/03/27 9.77% 22.08% 17.55% 0% 5.18% 5.53% 5.37% 0% 0.03% 0%
2025/03/28 0.53% 19.25% 15.14% 4.78% 4.34% 4.81% 4.72% 0.01% 0% 0%
2025/03/29 12.88% 19.99% 15.75% 3.15% 4.53% 7.1% 3.28% 0.01% 0.26% 0%
2025/03/30 13.03% 13.66% 13.6% 13.36% 2.81% 4.36% 7.11% 0.01% 0% 0%
2025/03/31 32.33% 19.06% 14.69% 4.96% 3.93% 3.41% 1.75% 0.04% 0% 0%

Copyright © Adthena. All rights reserved.

March saw dynamic shifts in PPC spend. Treatmyuti.com surged to 32.33% on March 31, while prevnar20.com peaked mid-month. Talk-prep.com and uqora.com showed steady growth, ending strong. Overall, March concluded with treatmyuti.com leading.

Market Exposure

Competitor Count for US Pharma & Biotech Infectious Diseases

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/03/01 100
2025/03/02 98
2025/03/03 89
2025/03/04 87
2025/03/05 89
2025/03/06 93
2025/03/07 97
2025/03/08 94
2025/03/09 87
2025/03/10 78
2025/03/11 77
2025/03/12 79
2025/03/13 78
2025/03/14 77
2025/03/15 64
2025/03/16 52
2025/03/17 56
2025/03/18 54
2025/03/19 57
2025/03/20 52
2025/03/21 59
2025/03/22 53
2025/03/23 59
2025/03/24 51
2025/03/25 48
2025/03/26 57
2025/03/27 56
2025/03/28 58
2025/03/29 59
2025/03/30 48
2025/03/31 46

Copyright © Adthena. All rights reserved.

March began with 100 advertisers, gradually declining to 46 by month’s end. Mid-month saw a sharp drop, stabilizing slightly before another dip.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Infectious Diseases

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
treatmyuti.com 7.6%
talk-prep.com 3.01%
prevnar20.com 2.15%
admired.com 2.09%
goodrx.com 1.71%
cabenuva.com -0.88%
uqora.com -1.5%
hellowisp.com -2.89%
solvwellness.com -3.71%
paxlovid.com -5.11%

Copyright © Adthena. All rights reserved.

Paxlovid.com saw a significant drop of 5.11%, while treatmyuti.com surged by 7.6%.

Campaign Efficiency

US Pharma & Biotech Infectious Diseases Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date treatmyuti.com uqora.com talk-prep.com prevnar20.com hellowisp.com viivhealthcare.com comirnaty.com skyrizi.com solvwellness.com admired.com
2025/03/01 19.37% 16.66% 2.94% 1.93% 20.68% 0.36% 1.21% 1.93% 0% 0%
2025/03/02 4.87% 30.5% 4.38% 1.49% 14.6% 0.47% 1.27% 0.54% 0% 0%
2025/03/03 4.31% 1.44% 6.01% 2.42% 22.71% 1% 3.36% 0.62% 1.44% 0%
2025/03/04 0.87% 21.77% 3.05% 2.45% 18.22% 1.4% 1.47% 0.7% 8.71% 4.35%
2025/03/05 0% 39.03% 1.07% 3.67% 7.94% 2.11% 2.12% 1.07% 13.01% 6.51%
2025/03/06 0% 13.02% 3.92% 11.7% 0.25% 8.3% 4.18% 2.77% 0% 0%
2025/03/07 8.74% 27.07% 1.33% 3.27% 12.51% 3.34% 1.22% 2.61% 3.63% 1.65%
2025/03/08 4.43% 16.28% 4.56% 6.22% 1.73% 5.97% 1.93% 6.26% 6.13% 6.13%
2025/03/09 0.27% 26.17% 3.81% 5.69% 14.21% 3.13% 2.81% 0.31% 12.81% 0%
2025/03/10 14.08% 26.28% 5.87% 9.05% 1.07% 2.88% 3.11% 4.34% 10.01% 0%
2025/03/11 14.36% 49.87% 3.39% 8.03% 3.65% 3.19% 2.38% 0.15% 0% 0%
2025/03/12 3.44% 2.29% 9.73% 13.56% 0.1% 10.86% 5.43% 2.86% 17.12% 0%
2025/03/13 6.94% 0.16% 10.59% 20.68% 0.12% 12.29% 5.79% 1% 0% 0%
2025/03/14 1.29% 0% 11.1% 18.06% 0.11% 5.72% 5.74% 4.76% 0% 0%
2025/03/15 1.78% 0% 8.91% 13.49% 0.05% 4.16% 2.96% 7.15% 13.3% 26.61%
2025/03/16 3.21% 0% 13.36% 16.25% 2.46% 12.09% 5.43% 8.67% 0% 0%
2025/03/17 2.46% 10.8% 5.1% 12.47% 0.1% 1.28% 5.1% 10.55% 0% 0%
2025/03/18 0% 49.99% 5.88% 15% 0.09% 1.27% 3.79% 0.74% 0% 0%
2025/03/19 12.34% 28.31% 4.79% 7.11% 7.92% 1.49% 1.79% 3.36% 0% 0%
2025/03/20 6.9% 52.42% 6.06% 8.31% 0.05% 1.47% 2.94% 3.74% 0% 0%
2025/03/21 0.9% 27.01% 6.64% 13.68% 0.06% 3.05% 3.06% 4.29% 0% 0%
2025/03/22 2.7% 12.78% 9.96% 9.08% 21.87% 3.39% 2.34% 1.7% 0.67% 10.08%
2025/03/23 16.5% 11.47% 2.5% 6.85% 11.18% 2.54% 2.5% 0.79% 10.79% 0%
2025/03/24 0.73% 0% 10.29% 6.15% 0.06% 4.44% 3.24% 3.95% 10.89% 22.5%
2025/03/25 18.26% 24.43% 7.04% 10.91% 1.97% 1.19% 3.42% 2.97% 4.4% 9.69%
2025/03/26 4.79% 10.54% 11.96% 8.34% 3.21% 3.21% 3.21% 8.71% 10.54% 10.54%
2025/03/27 18.6% 0% 13.95% 9.81% 2.54% 6.09% 3.73% 4.67% 0% 0%
2025/03/28 1.18% 17.59% 9.65% 7.1% 1.8% 4.88% 3.11% 0.63% 0% 17.59%
2025/03/29 22.23% 12.58% 10.99% 8.02% 0.06% 6.41% 1.69% 1.04% 0% 0%
2025/03/30 17.86% 35.77% 8.63% 4.16% 0.05% 2.3% 3.29% 0.36% 0% 9.15%
2025/03/31 50.1% 9.46% 9.12% 6.59% 4.37% 3.96% 3.83% 0.72% 0% 0%

Copyright © Adthena. All rights reserved.

In March 2025, “treatmyuti.com” saw a dramatic rise, peaking at 50.1% on the 31st. “uqora.com” maintained strong visibility, with a notable 52.42% on the 20th. “hellowisp.com” fluctuated, ending at 4.37%. Overall, “treatmyuti.com” dominated the month’s end.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Infectious Diseases

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Request Paxlovid For COVID-19 - No Appointments Needed https://health.amazon.com

    Start a virtual visit for as low as $29 to request a prescription for Paxlovid. Tested positive for...

  2. 2
    Did You Get A COVID-19 Shot? - Find Info On Side Effects Prescription vaccine website

    Learn About A 2024-2025 Formula COVID-19 Vaccine Option For 12 Yrs & Older.

  3. 3
    PREVNAR 20® By Pfizer | PREVNAR 20® Official Site https://www.prevnar20.com

    Talk To Your Doctor About PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine). Visit The Official Site To Find Patient Safety & Prescribing Info For PREVNAR 20®.

  4. 4
    Sick Of Antibiotics For UTIs? - Finally, UTI Relief That Works https://www.uqora.com › uti › relief

    Urinary tract health company Uqora breaks down the role antibiotics play in recurring UTIs

  5. 5
    HCPs: Switch HIV-1 Treatments - HIV-1 Treatment Option https://www.viivhealthcare.com

    HCPs: Do Your Patients Have Difficulty Remembering To Take Their Oral Treatments Daily? Hear Patient Perspectives. Videos For HCPs.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals and biotech, Amazon’s ad stands out by offering Paxlovid prescriptions without appointments, emphasizing convenience. Comirnaty focuses on COVID-19 vaccine updates, targeting informed consumers. Pfizer’s PREVNAR 20® ad highlights safety and doctor consultations. Uqora addresses UTI relief beyond antibiotics, while ViiV Healthcare targets healthcare professionals with HIV-1 treatment options. These ads collectively underscore themes of accessibility, innovation, and patient-centric solutions.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.